GlycanAge

Biological age FAQ: what biological age is, how testing works, and answers on results and lifestyle.

GlycanAge offers a quick health quiz assessing wellness scores, biological age, and inflammation.

Users can select between purchasing a GlycanAge test for personal use or for healthcare practice.

The page pairs the Vidavii recovery circuit with GlycanAge biological age testing for tracking health changes.

GlycanAge explains IgG glycans, biological clocks, and disease risk in detailed articles.

The page discusses health, inflammation, glycans, immune aging, blood tests, and biological age.

Customer and expert stories share GlycanAge results and lifestyle improvements.

GlycanAge’s research is supported by over 350 scientific publications spanning 30+ years.

The company introduces its team, including founders and a science advisory board.

The company’s mission is to translate glycan science into accessible, preventative healthcare tools.

Glycans reflect chronic inflammation, and GlycanAge analyzes them for health insights.

The only biological age test that accurately measures your unique response to life changes. Discover your biological age and make lifestyle improvements!

GlycanAge describes its use of cookies and similar technologies and user choice management.

The page details GlycanAge’s Privacy Policy and Cookie Policy, including user choice management.

The page outlines GlycanAge’s order cancellation, return, and refund policies.

The company requires acceptance of standard terms and conditions for service use.

GlycanAge, a Croatian-founded biotech startup, partners with Unilabs to offer its biological-age test in Abu Dhabi. The company, backed by Bulgarian investment firm ImPulse Growth, now provides access to the service through Unilabs’ diagnostics network in the region. GlycanAge’s test evaluates biological age as a health metric, expanding its reach beyond the UK.

Oct 2026SeeNewsNews article

GlycanAge partners with ExoEarth to integrate its glycan-based biological age test with ExoEarth’s exosome platform. The collaboration expands inflammaging research capabilities in Japan through a new memorandum of understanding (MOU).

Sep 2026Longevity.TechnologyNews article

GlycanAge convenes academics and clinicians in Dubrovnik to mark 25 years of inflammaging research and advance chronic-inflammation testing into clinical practice. The company specializes in measuring glycans—sugar molecules regulating protein function—to assess biological age. This conference aims to bridge research and real-world medical applications for inflammaging diagnostics.

May 2026Yahoo FinanceNews article

GlycanAge secures **€7.4 million** in funding to advance its glycan-based technology for clinical use. The biotech startup, founded by Croatians but UK-based, aims to expand global access for clinicians through its development pipeline. The round supports scaling operations and clinical trials.

Dec 2025SeeNewsNews article